Acciones Eastgate Biotech Corp. Other OTC
Acciones
ETBI
US2772531008
Farmacéuticos
Ventas 2015 | 0,13 0,12 | Ventas 2016 | - | Capitalización | 9,82 M 9,17 M |
---|---|---|---|---|---|
Resultado Neto 2015 | -4 M -3,73 M | Resultado Neto 2016 | -2 M -1,87 M | VE / Ventas 2015 | 52.069.161 x |
Deuda neta 2015 | 1,35 M 1,26 M | Deuda neta 2016 | 1,72 M 1,6 M | VE / Ventas 2016 | - |
P/E ratio 2015 |
-0,85
x | P/E ratio 2016 |
-3,28
x | Empleados | - |
Rendimiento 2015 * |
-
| Rendimiento 2016 |
-
| Flotante | 100 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Rose Perri
CEO | Chief Executive Officer | 55 | 15/01/15 |
William Abajian
PSD | President | 66 | 01/06/16 |
Ishaan Sundar
CTO | Chief Tech/Sci/R&D Officer | - | 12/04/17 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Anna Gluskin
BRD | Director/Board Member | 68 | 22/05/12 |
Rose Perri
CEO | Chief Executive Officer | 55 | 15/01/15 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+55,32 % | 819 mil M | |
-6,75 % | 351 mil M | |
+13,56 % | 329 mil M | |
+10,68 % | 298 mil M | |
+16,57 % | 242 mil M | |
+2,04 % | 225 mil M | |
+13,31 % | 217 mil M | |
+8,48 % | 168 mil M | |
-2,81 % | 158 mil M |